Singapore - Medicaments of Antibiotics other than Penicillins, Streptomycins or their Derivatives - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingSingapore: Market for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives 2024
Market Size for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Singapore
The Singaporean market for medicaments of antibiotics other than penicillins, streptomycins or their derivatives reached $X in 2023, with an increase of X% against the previous year. Overall, consumption, however, recorded a drastic downturn. Non-penicillin or streptomycin antibiotic medicaments consumption peaked at $X in 2015; however, from 2016 to 2023, consumption failed to regain momentum.
Production of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Singapore
In value terms, non-penicillin or streptomycin antibiotic medicaments production declined sharply to $X in 2023 estimated in export price. Overall, production faced a deep contraction. The most prominent rate of growth was recorded in 2022 when the production volume increased by X% against the previous year. Over the period under review, production reached the peak level at $X in 2015; however, from 2016 to 2023, production failed to regain momentum.
Exports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives
Exports from Singapore
For the fourth consecutive year, Singapore recorded decline in overseas shipments of medicaments of antibiotics other than penicillins, streptomycins or their derivatives, which decreased by X% to X tons in 2023. Over the period under review, exports, however, recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2017 with an increase of X% against the previous year. As a result, the exports reached the peak of X tons. From 2018 to 2023, the growth of the exports failed to regain momentum.
In value terms, non-penicillin or streptomycin antibiotic medicaments exports contracted remarkably to $X in 2023. Overall, exports, however, posted prominent growth. The pace of growth was the most pronounced in 2015 with an increase of X%. As a result, the exports attained the peak of $X. From 2016 to 2023, the growth of the exports failed to regain momentum.
Exports by Country
Oman (X tons), Indonesia (X tons) and South Korea (X tons) were the main destinations of non-penicillin or streptomycin antibiotic medicaments exports from Singapore, together accounting for X% of total exports. Slovenia, Angola, Myanmar, Malaysia, Thailand, the United Arab Emirates, Brunei Darussalam, Uzbekistan, Tanzania and Vietnam lagged somewhat behind, together accounting for a further X%.
From 2012 to 2023, the biggest increases were recorded for the United Arab Emirates (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.
In value terms, the largest markets for non-penicillin or streptomycin antibiotic medicaments exported from Singapore were Slovenia ($X), Thailand ($X) and Indonesia ($X), together accounting for X% of total exports. South Korea, Malaysia, Uzbekistan, the United Arab Emirates, Myanmar, Vietnam, Oman, Brunei Darussalam, Angola and Tanzania lagged somewhat behind, together comprising a further X%.
The United Arab Emirates, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
The average export price for medicaments of antibiotics other than penicillins, streptomycins or their derivatives stood at $X per ton in 2023, falling by X% against the previous year. Overall, the export price, however, continues to indicate strong growth. The growth pace was the most rapid in 2022 an increase of X% against the previous year. As a result, the export price attained the peak level of $X per ton, and then contracted significantly in the following year.
There were significant differences in the average prices for the major export markets. In 2023, amid the top suppliers, the country with the highest price was Thailand ($X per ton), while the average price for exports to Tanzania ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Slovenia (X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives
Imports into Singapore
Non-penicillin or streptomycin antibiotic medicaments imports into Singapore declined markedly to X tons in 2023, waning by X% compared with the year before. Over the period under review, imports, however, saw a perceptible increase. The most prominent rate of growth was recorded in 2015 with an increase of X%. Over the period under review, imports attained the maximum at X tons in 2021; however, from 2022 to 2023, imports stood at a somewhat lower figure.
In value terms, non-penicillin or streptomycin antibiotic medicaments imports contracted dramatically to $X in 2023. Overall, imports, however, recorded a remarkable increase. The pace of growth appeared the most rapid in 2017 when imports increased by X%. Over the period under review, imports reached the maximum at $X in 2020; however, from 2021 to 2023, imports stood at a somewhat lower figure.
Imports by Country
China (X tons), India (X tons) and Ireland (X tons) were the main suppliers of non-penicillin or streptomycin antibiotic medicaments imports to Singapore, with a combined X% share of total imports. Malaysia, Indonesia, Germany, France, South Korea, Belgium, Spain, Italy, Switzerland and Cyprus lagged somewhat behind, together comprising a further X%.
From 2012 to 2023, the biggest increases were recorded for Cyprus (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.
In value terms, the largest non-penicillin or streptomycin antibiotic medicaments suppliers to Singapore were India ($X), Switzerland ($X) and Belgium ($X), with a combined X% share of total imports. Italy, China, Germany, France, Indonesia, Malaysia, Cyprus, Ireland, South Korea and Spain lagged somewhat behind, together accounting for a further X%.
Among the main suppliers, Cyprus, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2023, the average import price for medicaments of antibiotics other than penicillins, streptomycins or their derivatives amounted to $X per ton, reducing by X% against the previous year. Over the period under review, the import price, however, recorded resilient growth. The most prominent rate of growth was recorded in 2022 when the average import price increased by X%. As a result, import price reached the peak level of $X per ton, and then reduced notably in the following year.
There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was Switzerland ($X per ton), while the price for China ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Switzerland (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in Singapore. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201150 - Medicaments of other antibiotics, n.p.r.s.
- Prodcom 21201180 - Medicaments of other antibiotics, p.r.s.
Country coverage:
- Singapore
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Singapore
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in Asia.
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in the U.S..
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in China.
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in the EU.
This report provides an in-depth analysis of the global market for non-penicillin or streptomycin antibiotic medicaments.
- Price for Medicaments of Other Antibiotics Singapore
- Non-Penicillin or Streptomycin Antibiotic Medicaments Market
- Hormones Market
- Glycosides and Vegetable Alkaloids Market
- Antibiotic Market
- Organ Extracts Market
- Antisera Market
- Biological Product Market
- Sterile Medical Adhesion Barrier Market
- Human and Animal Blood Market